LivaNova (LIVN) Cash from Investing Activities (2015 - 2026)

LivaNova (LIVN) reported Cash from Investing Activities of -$14.6 million for Q1 2026, down 37.18% on a YoY basis from -$23.2 million in Q1 2025, and up 51.82% sequentially from -$30.3 million in Q4 2025.

LivaNova (LIVN) Cash from Investing Activities (2015 - 2026) Analysis & Trends

LivaNova (LIVN) has 12 years of Cash from Investing Activities data on file, last reported at -$14.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities fell 37.18% year-over-year to -$14.6 million; the trailing twelve-month figure through Mar 2026 stood at -$76.9 million (down 46.62% YoY), and the FY2025 full-year result was -$72.9 million, down 51.4% from the prior year.
  • Cash from Investing Activities grew to -$14.6 million in Q1 2026, from -$30.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$5.5 million in Q1 2022 to a low of -$30.3 million in Q4 2025.
  • A 5-year average of -$12.6 million and a median of -$11.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities plunged 201.65% in 2022 and jumped 58.79% in 2023, its largest moves.
  • Tracing LIVN's Cash from Investing Activities over 5 years: stood at -$11.0 million in 2022, then fell by 10.82% to -$12.1 million in 2023, then increased by 11.78% to -$10.7 million in 2024, then tumbled by 182.58% to -$30.3 million in 2025, then soared by 51.82% to -$14.6 million in 2026.
  • Business Quant data shows LIVN's Cash from Investing Activities at -$14.6 million in Q1 2026, -$30.3 million in Q4 2025, and -$23.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 LivaNova 4.40 Bn 3.86 Bn 243.75 Mn -14.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.58 Mn
Mar 31, 2026 -14.58 Mn
Dec 31, 2025 -30.26 Mn
Dec 31, 2025 -30.26 Mn
Sep 30, 2025 -23.06 Mn
Sep 30, 2025 -23.06 Mn
Jun 30, 2025 -8.97 Mn
Jun 30, 2025 -8.97 Mn
Mar 31, 2025 -10.63 Mn
Mar 31, 2025 -10.63 Mn
Dec 31, 2024 -10.71 Mn
Dec 31, 2024 -10.71 Mn
Sep 30, 2024 -18.52 Mn
Sep 30, 2024 -18.52 Mn
Jun 30, 2024 -12.57 Mn
Jun 30, 2024 -12.57 Mn
Mar 31, 2024 -6.36 Mn
Mar 31, 2024 -6.36 Mn
Dec 31, 2023 -12.14 Mn
Dec 31, 2023 -12.14 Mn